| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
For nearly a century, Encompass has been helping health care and hospitality organizations create safe, comfortable environments for patients, staff, residents and guests. Whether developing advanced hypothermia prevention products, helping hospitals contain the spread of infections, or designing interiors for new, state-of-the-art retirement communities, we offer a complete line of products, services and education programs that meet the challenges our customers face every day.
TeleDiagnostic Systems is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Whip Mix is the one resource that helps the Dental Profession achieve its goals of high quality, less invasive patient care, reduced chair time and increased operating efficiencies.
Roby Institute CALM International Online Allergy Center is a Austin, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.